In the DIAST-CHF study, galectin-3 levels exceeding 313.57 ng/mL were found to predict incident HFpEF, adjusted all-cause mortality, and the adjusted composite of cardiovascular hospitalization and death [82]. This evidence concerns the gene LGALS3 and congestive heart failure.